Globus Medical, Inc. reported $657,293 million in sales and $60,275 million in operating profit for the quarter ending ...

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced Modulus ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus ALIF blades. The Cohere space is the first porous ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

OsteoCentric Technologies has entered into a non-exclusive licensing agreement with Globus Medical.  OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the ...

AUSTIN, Texas, March 11, 2025 /PRNewswire/ -- OsteoCentric Technologies, a global leader in innovative medical technologies, ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Charles Schwab Investment Management Inc. lowered its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.83% on an annualized basis producing an average ...